The 50-minute session will focus on safety concerns with labelling of IV fluids, strategies to mitigate fluoropyrimidine toxicity and the National System for Incident Reporting transition.
A study conducted in Ontario shows that the use of first-generation antihistamines increases the risk of delirium in hospitalized seniors—calling for a review of certain prescribing practices.
Canadian researchers examine whether the addition of acetaminophen or hydromorphone to ibuprofen improves pain relief in children with acute limb injury.
A Health Canada safety review examines the use of dimethyl fumarate and the risk of gastrointestinal events of perforation, ulceration, hemorrhage and obstruction.
As of Dec. 29, Health Canada had received nine submissions seeking approval to make semaglutide, the active ingredient in Ozempic and Wegovy, the brand-name diabetes and weight-loss drugs manufactured by Novo Nordisk.
Canadian Rheumatology Association advocates for greater pediatric access to JAK inhibitors, which can be given orally rather than subcutaneously or intravenously.
Canadian Paediatric Society issues guidance on managing moderate to severe migraine in children unresponsive to home therapy with acetaminophen, ibuprofen and/or a triptan.
